Rubius Therapeutics Inc (OTC Pink - Limited Information:RUBY)
| 0.0218 Delayed Data As of Jun 02 |  +0.0007 / +3.32%Today’s Change | 0.01 Today|||52-Week Range 1.57 | -87.54% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $2.0M |
Company Description
Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA.
Contact Information
Rubius Therapeutics, Inc. 124 Washington Street Foxboro Massachusetts 02035 |
Employees
Shareholders
| Individual stakeholders | 50.31% |
| Other institutional | 3.00% |
| Mutual fund holders | 0.73% |
Top Executives
| Craig R. Jalbert | President, Treasurer, Secretary & Director |
| James Jogerst | Chief Business Officer |
| Lori Murray | Chief Corporate Affairs Officer |
| Tamyra A. Toole | Vice President-Regulatory Affairs |
